Navigation Links
Genes found linked to breast cancer drug resistance could guide future treatment choices
Date:1/24/2010

BOSTON--Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.

Despite their resistance to drugs of the anthracycline class, the breast cancers bearing this gene signature will probably still be vulnerable to other types of chemotherapy agents, say scientists in a letter to be published in Nature Medicine on its Web site and later in a print edition. Thus, the findings could lead to a genetic test of breast cancers to help physicians choose the best initial treatment for an individual patient.

With this guidance, physicians could avoid the current trial-and-error approach that in some cases exposes patients to the toxic side effects of a cancer drug that is destined to be ineffective. The new report underscores the potential of personalized cancer care, in which knowing the specific molecular features of a patient's cancer helps direct the course of care.

The investigators from the Dana-Farber Women's Cancers Program undertook the studies to search for molecular traits in tumors that cause some patients to suffer recurrences in the wake of breast cancer surgery despite post-surgery, or "adjuvant," chemotherapy, while other patients do well for many years.

Led by Andrea Richardson, MD, PhD, and Zhigang Charles Wang, MD, PhD, the investigators identified two genes that, when abnormally active, enabled cancer cells to resist the effects of drugs called anthracyclines. This class of agents includes doxorubicin, daunorubicin, and epirubicin, which are often used as adjuvant therapy in breast cancer.

The scientists probed stored breast tumor specimens from 85 patients and found the gene signature associated with drug resistance in about 1 in 5 samples, according to the report. Clinical records on file showed that those patients had poorer o
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. In early heart development, genes work in tandem
2. Why do people play the longshot and buy insurance? Its in our genes
3. Genes for drought-tolerance, aflatoxin may mingle to boost corn production
4. New RNA interference technique can silence up to 5 genes
5. There may be a party in your genes
6. New genes for lung disease discovered
7. Extreme genes shed light on origins of photosynthesis
8. Happy holidays from the groaning board; Western diets turn on fat genes
9. Maize cell wall genes identified, giving boost to biofuel research
10. Largest gene study of childhood IBD identifies 5 new genes
11. Longevity tied to genes that preserve tips of chromosomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Va. , Dec. 15, 2014 The Defense ... easier to detect and prevent counterfeit microcircuits from entering ... started performing an in-house microcircuit anti-counterfeit initiative dubbed DNA ... microcircuits while increasing their reliability throughout the supply chain. ...
(Date:12/15/2014)... and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) has announced ... 2015-2019" report to their offering. ... a technology used for the identification of individuals. Facial ... person such as nose, jaw edges, mouth, and the ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been here before: ... can,t remember your password, site key or the answer to your ... teacher? Today, Hoyos Labs , a digital ... put an end to the frustration that comes with usernames, passwords ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... Francisco, and collaborators at Harvard Medical School have linked ... that clears glucose out of the bloodstream, shedding light ... a cellular level. Establishing the function ... mice, has broad implications for both the future study ...
... Secretary Steve Chu are consistent in their message that ... an alternative to gasoline are coming. While the focus ... on global warming, such a shift could also impact ... (EBI) has produced a novel and comprehensive "Life Cycle ...
... cherry juice could help ease the pain for people who ... University presented at the American College of Sports Medicine Conference ... tart cherry juice while training for a long distance run ... Post-exercise pain can often indicate muscle damage or debilitating ...
Cached Biology News:UCSF discovers new glucose-regulating protein linked with diabetes 2The coming of biofuels: Study shows reducing gasoline emissions will benefit human health 2The coming of biofuels: Study shows reducing gasoline emissions will benefit human health 3The coming of biofuels: Study shows reducing gasoline emissions will benefit human health 4Is cherry juice a new 'sports drink?' 2
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project managed ... legal requirements around using controlled substances in pharmaceutical research, ... their international operations expand and become increasingly complex, large ... a result of the first phase of the CSCS ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2
... Report the Use of Haptoglobin Typing,to Predict Cardiovascular ... MONTVALE, N.J., Nov. 10 Synvista,Therapeutics, Inc. ... Annual Scientific,Sessions of the American Heart Association, underway ... determine haptoglobin (Hp) genotype utilizing,intellectual property licensed from ...
... Nov. 10 SenesTech, Inc. has launched,the regulatory ... the first,ContraPest(R) product with the government of Australia. ... rice field rat species, registration,of ContraPest(R) bait will ... management product to the agricultural ministries of Southeast,Asia. ...
... with more than $500 million in ... cash - Conference ... ... ISIS ) today announced its financial results,for the third quarter ended September 30, 2008. Isis, ...
Cached Biology Technology:Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 2Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 3Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 4Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 5SenesTech, Inc. Commences Product Registration Process With Australian Government 2Isis Reports Financial Results and Highlights for Third Quarter of 2008 2Isis Reports Financial Results and Highlights for Third Quarter of 2008 3Isis Reports Financial Results and Highlights for Third Quarter of 2008 4Isis Reports Financial Results and Highlights for Third Quarter of 2008 5Isis Reports Financial Results and Highlights for Third Quarter of 2008 6Isis Reports Financial Results and Highlights for Third Quarter of 2008 7Isis Reports Financial Results and Highlights for Third Quarter of 2008 8Isis Reports Financial Results and Highlights for Third Quarter of 2008 9Isis Reports Financial Results and Highlights for Third Quarter of 2008 10Isis Reports Financial Results and Highlights for Third Quarter of 2008 11Isis Reports Financial Results and Highlights for Third Quarter of 2008 12Isis Reports Financial Results and Highlights for Third Quarter of 2008 13Isis Reports Financial Results and Highlights for Third Quarter of 2008 14Isis Reports Financial Results and Highlights for Third Quarter of 2008 15
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
... ES1301 mutS are mismatch repair minus strains ... prevents repair of the newly synthesized unmethylated ... and making them helpful in such systems ... Mutagenesis Systems. Both ES1301 and BMH 71-18 ...
propidium iodide *1.0 mg/mL solution in water*...
Applications: (+) Immunocytochemistry and immunohistochemistry...
Biology Products: